GEMZAR AS PROLONGED INFUSION IN COMBINATION WITH PACLITAXEL IN ANTHRACYCLINE PRETREATED METASATTIC BREAST CANCER

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2004-003999-11-IT

Enrollment

Registered

2005-03-09

Start date

2004-12-30

Completion date

Unknown

Last updated

2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

TREATMENT OF ANTHRACYCLINE PRETREATED METASTATIC BREAST CANCER MedDRA version: 6.1 Level: PT Classification code 10055113

Interventions

Trade Name: GEMZAR*1G POLV. EV 1 FL Product Name: NA Product Code: NA Pharmaceutical Form: Powder for infusion* INN or Proposed INN: Gemcitabine CAS Number: 122111-03-9 Concentration unit: mg milligra

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026